SCHEMBL3470930

SCHEMBL3470930

Cc1cccc(C#N)c1N1CCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
KDM4E B2RXH2 6/20 0.51
TSHR P16473 4/20 0.49
ALOX15 P16050 3/20 0.49
CASP1 P29466 3/20 0.49
CASP7 P55210 3/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
C5AR1 P21730 1/20 0.42
MAPT P10636 3/20 0.41
MEN1 O00255 1/20 0.41
CRHBP P24387 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
CRHR2 Q13324 1/20 0.41
USP2 O75604 2/20 0.40
CLK1 P49759 1/20 0.40
HSD17B10 Q99714 2/20 0.40
AR P10275 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17871835 0.95 TSHR (0.51) ALDH1A1KDM4ETSHRALOX15CASP1
SCHEMBL30164060 0.85 ADRB1 (0.50) ALDH1A1KDM4ETSHR
SCHEMBL3554062 0.78 DRD4 (0.46) ALDH1A1KDM4ETSHRL3MBTL1C5AR1
SCHEMBL15462283 0.76 ALDH1A1 (0.61) ALDH1A1KDM4ETSHRL3MBTL1MAPT
SCHEMBL3436602 0.76 DRD4 (0.47) ALDH1A1KDM4EL3MBTL1C5AR1MAPT
SCHEMBL3470934 0.75 ALDH1A1 (0.47) ALDH1A1KDM4ETSHRALOX15CASP1
SCHEMBL11922737 0.74 ALDH1A1 (0.65) ALDH1A1KDM4ETSHRL3MBTL1MAPT
SCHEMBL5793581 0.74 KDM4E (0.50) ALDH1A1KDM4ETSHRALOX15CASP1
SCHEMBL16793252 0.74 ALDH1A1 (0.54) ALDH1A1KDM4ETSHRALOX15CASP1
SCHEMBL20142715 0.74 ALDH1A1 (0.50) ALDH1A1KDM4ETSHRALOX15CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014019186-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2014-02-06 WO disclosed
WO-2010071750-A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2010-06-24 WO disclosed
EP-1960392-A2 HETEROCYCLE-SUBSTITUTED 3-ALKYL AZETIDINE DERIVATIVES Merck & Co., Inc. (US) 2008-08-27 EP disclosed
WO-2007064566-A2 HETEROCYCLE-SUBSTITUTED 3-ALKYL AZETIDINE DERIVATIVES MERCK & CO., INC. (US) 2007-06-07 WO disclosed